351 results on '"Akkerhuis, K. Martijn"'
Search Results
2. Targeted proteomics and metabolomics for biomarker discovery in abdominal aortic aneurysm and post-EVAR sac volume
3. HFrEF subphenotypes based on 4210 repeatedly measured circulating proteins are driven by different biological mechanisms
4. Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study)
5. Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical investigation of 92 biomarkers (Bio-SHiFT study)
6. Proteomic biomarkers related to obesity in heart failure with reduced ejection fraction and their associations with outcome.
7. Personalized screening intervals for kidney function in patients with chronic heart failure: a modeling study
8. Abstract 12012: Subphenotypes of Heart Failure With Reduced Ejection Fraction Based on Repeated Measurements of 4210 Circulating Proteins Are Driven by Protein Subsets Reflecting Different Biological Mechanisms
9. Identifying plasma proteomic signatures from health to heart failure, across the ejection fraction spectrum.
10. Temporal evolution of liver function parameters predicts clinical outcome in chronic heart failure patients (Bio-SHiFT study).
11. Sex‐specific cardiovascular protein levels and their link with clinical outcome in heart failure
12. Machine learning–based biomarker profile derived from 4210 serially measured proteins predicts clinical outcome of patients with heart failure
13. A heart failure phenotype stratified model for predicting 1-year mortality in patients admitted with acute heart failure: results from an individual participant data meta-analysis of four prospective European cohorts
14. Temporal Pattern of Growth Differentiation Factor-15 Protein After Acute Coronary Syndrome (From the BIOMArCS Study)
15. Prognostic Value of Intravascular Ultrasound in Patients With Coronary Artery Disease
16. Sex‐specific cardiovascular protein levels and their link with clinical outcome in heart failure.
17. Circulating biomarkers of cardiovascular disease are related to aneurysm volume in abdominal aortic aneurysm
18. Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study
19. Circulating biomarkers of cardiovascular disease are related to aneurysm volume in abdominal aortic aneurysm
20. Serially Measured hs-cTnT, NT-proBNP, hs-CRP and GDF-15 for Risk Assessment After Acute Coronary Syndrome: the BIOMArCS Cohort
21. Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study
22. Plasma cystatin C and neutrophil gelatinase-associated lipocalin in relation to coronary atherosclerosis on intravascular ultrasound and cardiovascular outcome: Impact of kidney function (ATHEROREMO-IVUS study)
23. Haptoglobin polymorphism in relation to coronary plaque characteristics on radiofrequency intravascular ultrasound and near-infrared spectroscopy in patients with coronary artery disease
24. Prognostic value of temporal patterns of global longitudinal strain in patients with chronic heart failure
25. Longitudinal profile of circulating endothelial cells in post-acute coronary syndrome patients
26. Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart Failure
27. PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study
28. High-sensitivity Troponin T in relation to coronary plaque characteristics in patients with stable coronary artery disease; results of the ATHEROREMO-IVUS study
29. sj-pdf-3-vmj-10.1177_1358863X231181159 – Supplemental material for Circulating biomarkers of cardiovascular disease are related to aneurysm volume in abdominal aortic aneurysm
30. sj-pdf-2-vmj-10.1177_1358863X231181159 – Supplemental material for Circulating biomarkers of cardiovascular disease are related to aneurysm volume in abdominal aortic aneurysm
31. sj-pdf-1-vmj-10.1177_1358863X231181159 – Supplemental material for Circulating biomarkers of cardiovascular disease are related to aneurysm volume in abdominal aortic aneurysm
32. Additional file 1 of Sex-based differences in cardiovascular proteomic profiles and their associations with adverse outcomes in patients with chronic heart failure
33. Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome: Results of the ATHEROREMO-IVUS study
34. High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary Syndrome: BIOMArCS Study
35. Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohort.
36. Prognostic value of syntax score, intravascular ultrasound and near-infrared spectroscopy to identify low-risk patients with coronary artery disease 5-year results from the ATHEROREMO and IBIS-3 cohorts
37. Circulating acute phase proteins in relation to extent and composition of coronary atherosclerosis and cardiovascular outcome: Results from the ATHEROREMO-IVUS study
38. Relation of C-Reactive Protein to Coronary Plaque Characteristics on Grayscale, Radiofrequency Intravascular Ultrasound, and Cardiovascular Outcome in Patients With Acute Coronary Syndrome or Stable Angina Pectoris (from the ATHEROREMO-IVUS Study)
39. Adenosine and Ticagrelor Plasma Levels in Patients With and Without Ticagrelor-Related Dyspnea
40. Development and validation of a risk model for long‐term mortality after percutaneous coronary intervention: The IDEA‐BIO Study
41. Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure
42. Abstract 19795: Clinical Determinants and Relation to Prognosis of Progressive Tubular Damage and Glomerular Decline in Chronic Heart Failure (Bio-SHiFT Study)
43. Associations of 26 Circulating Inflammatory and Renal Biomarkers with Near-Infrared Spectroscopy and Long-term Cardiovascular Outcome in Patients Undergoing Coronary Angiography (ATHEROREMO-NIRS Substudy)
44. CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study
45. Relation of Iron Status to Prognosis After Acute Coronary Syndrome
46. Persistently elevated levels of sST2 after acute coronary syndrome are associated with recurrent cardiac events
47. Fibrinogen in relation to degree and composition of coronary plaque on intravascular ultrasound in patients undergoing coronary angiography
48. IGF-1 is not related to long-term outcome in hyperglycemic acute coronary syndrome patients
49. Determinants of quality of life in acute heart failure patients with and without comorbidities: a prospective, observational study
50. Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEF
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.